Found: 3
Select item for more details and to access through your institution.
A multi‐targeted treatment approach to cancer cachexia: Auckland's Cancer Cachexia evaluating Resistance Training (ACCeRT) trial.
- Published in:
- JCSM Rapid Communications, 2020, v. 3, n. 1, p. 11, doi. 10.1002/rco2.10
- By:
- Publication type:
- Article
A multi‐targeted treatment approach to cancer cachexia: Auckland's Cancer Cachexia evaluating Resistance Training (ACCeRT) trial.
- Published in:
- JCSM Rapid Communications, 2020, v. 3, n. 1, p. 11, doi. 10.1002/rco2.10
- By:
- Publication type:
- Article
A randomised feasibility study of EPA and Cox-2 inhibitor (Celebrex) versus EPA, Cox-2 inhibitor (Celebrex), resistance training followed by ingestion of essential amino acids high in leucine in NSCLC cachectic patients--ACCeRT study.
- Published in:
- 2011
- By:
- Publication type:
- journal article